Page 165 - Feline Cardiology
P. 165

164  Section D: Cardiomyopathies


              discharged with furosemide 12.5 mg PO q 12 h for a few   ommended. Aldactazide is a combination of hydrochlo-
              days, if mild dyspnea is still present at the time of dis-  rothiazide  and  spironolactone,  which  is  used  in  dogs
              charge, and then the furosemide can be decreased to the   with refractory heart failure, but it may not be as attrac-
              minimal tolerated dose to achieve RR <40 and normal   tive for use in cats given the possibility of an adverse
              effort (6.25 mg PO q 12 h is a typical maintenance dose).   reaction to spironolactone.
              In  cats  with  significant  azotemia  (BUN  70 mg/dl   A low salt diet may be implemented, if palatable, in
              (25 mmol/l) or higher, creatinine 3 mg/dl (264 mmol/l)   cats receiving moderate furosemide doses and an ACE
              or higher) and resolved heart failure, a lower starting dose   inhibitor.  Low  salt  cardiovascular  diets  contain  0.15–
              of furosemide of 6.25 mg PO q 12–24 h may be more   0.2 g sodium/1000 kcal, and help limit sodium and water
              appropriate. The owner should be taught how to count   retention. The nutritional priority in cats is to maintain
      Cardiomyopathies  ratory  effort  at  home  and  instructed  to  keep  a  daily   atable low-salt diet to a cat that remains anorexic. Low-
                                                                 an adequate caloric intake, rather than forcing an unpal-
              the resting respiratory rate and qualitatively assess respi-
                                                                 salt diets are available as prescription commercial diets
              written log. This is highly beneficial for making decisions
                                                                 (Purina CV or Hills H/D) or one can be formulated by
              regarding dosage adjustment in individual patients.
                                                                 a  nutrition  service.  Owner-formulated  home-cooked
              Refractory congestive heart failure
                                                                 erinary nutritionist (useful resources include balanceit.
              Refractory heart failure is present when clinical signs of   diets are discouraged unless they are balanced by a vet-
              dyspnea  continue  occur  due  to  persistent  pulmonary   com; Home-prepared Dog and Cat Diets, The Healthful
              edema and/or pleural effusion despite increasing doses   Alternative,  DR  Strombeck,  1999.)  Low-salt  diets  also
              or maximal dose of furosemide (3–4 mg/kg PO q 8–12 h)   activate  RAAS,  so  cats  should  also  be  given  an  ACE
              in a compliant patient that is reliably receiving the medi-  inhibitor. Renal diets are protein restricted, which may
              cation.  Cats  commonly  have  progressive  heart  failure   hasten development of cachexia in heart failure patients.
              over time, requiring up-titration of the furosemide dose,   They may be indicated in patients with concurrent mod-
              yet refractory heart failure requiring 4 mg/kg PO q 8 h is   erate to severe renal disease and heart failure.
              unusual.  In  cats  requiring  maximal  furosemide  doses,
              the issue of owner and patient compliance with medica-  Prophylactic anticoagulant therapy
              tion  administration  should  be  investigated,  and  com-  Prophylactic anticoagulant therapy is indicated in cats
              pounding the furosemide may be an option in cats that   that  have  had  a  history  of  ATE  or  have  echocardio-
              resent the pill form. Mild to moderate prerenal azotemia   graphic evidence of spontaneous contrast (i.e., red blood
              and  dehydration  are  expected  in  cats  receiving  high   cell aggregation) or intracardiac thrombus. Some cardi-
              doses of furosemide but are a necessary evil compared   ologists, including the authors, use prophylactic antico-
              to  life-threatening  dyspnea  from  progressive  heart   agulant therapy in cats with moderate or severe left atrial
              failure.  Some  cats  are  intolerant  to  high  furosemide   dilation, who are likely at greater risk of developing ATE.
              doses and develop symptoms referable to dehydration   The  incidence  of  ATE  in  cats  with  HCM  is  16–18%
              and azotemia. The furosemide dose may be decreased in   (Rush  et  al.  2002;  Atkins  et  al.  1992).  Anticoagulant
              these  cases,  and  if  there  is  a  lack  of  improvement  in   choices include low-dose aspirin (5–81 mg PO q 3 days),
              symptoms  of  dehydration,  one  or  two  subcutaneous   clopidogrel (18.75 mg PO q 24 hr with food), low molec-
              fluid administrations with low volumes (50–60 ml) may   ular weight heparin (Lovenox 1.5 mg/kg SC BID-TID),
              be given temporarily but not on an ongoing basis. In cats   or warfarin. There are no controlled studies comparing
              with concurrent symptoms from severe dehydration and   effects  of  the  most  commonly  used  anticoagulants
              azotemia as well as severe dyspnea from congestive heart   (aspirin, clopidogrel, and enoxaparin) on development
              failure, no effective therapy exists and euthanasia may   of arterial thromboembolism in cats, although a large
              be a feasible option.                              multicenter study in cats suffering from ATE that were
                 Cats  with  significant  heart  failure  despite  maximal   treated  with  aspirin  versus  clopidogrel  has  been  con-
              furosemide doses may benefit from addition of hydro-  ducted and results are pending. In cats with spontane-
              chlorothiazide (1–2 mg/kg PO q 12–24 h) starting at the   ous  contrast  seen  by  echocardiography,  repeat
              low  end  of  the  dose  and  increasing  as  necessary.   echocardiographic assessment of spontaneous contrast
              Spironolactone is not a very effective diuretic but may   should  be  done  after  anticoagulant  therapy  is  started,
              provide  adjunctive  treatment  to  reduce  hypokalemia   and combination therapy may be needed for cats with
              and reduce some of the deleterious effects of aldoste-  persistent spontaneous contrast.
              rone. In a study of 26 cats with asymptomatic HCM, 1/3
              of  cats  treated  with  spironolactone  developed  severe   Medications Not Indicated or Contraindicated
              ulcerative facial dermatitis 2.5 months after treatment,   Because taurine and carnitine deficiencies do not cause
              so careful monitoring for adverse skin reactions is rec-  or  contribute  to  development  of  HCM,  their  supple-
   160   161   162   163   164   165   166   167   168   169   170